Results 1 to 10 of about 288,999 (267)
Some of the next articles are maybe not open access.

Oligonucleotide therapeutics

Trends in Biotechnology, 1992
Recent studies have focused on the ability of oligonucleotides to affect the genetic processes of many organisms, including viruses. Hence, oligonucleotides may represent a future source of biotechnologically derived compounds of therapeutic importance for diseases such as cancer and AIDS.
openaire   +2 more sources

Diagnosis with oligonucleotides

Clinics in Dermatology, 1991
Abstract Protein-based immunohistochemical techniques like immunoperoxidase methods are now routinely used in many diagnostic dermatopathology laboratories. This is possible because of the availability of antibodies that react with specific, diagnostically useful proteins and because there are simple but sensitive detection systems.
openaire   +2 more sources

Oligonucleotide therapy

Current Opinion in Biotechnology, 1992
Rapid progress in oligonucleotide therapeutics has continued over the past year as major programs established in the past four years have grown and begun to be productive. Important advances were reported in the medicinal chemistry of oligonucleotides and in understanding their pharmacodynamic properties.
openaire   +2 more sources

Therapeutic Oligonucleotides

2011
A brief historical introduction describes early attempts to silence specific genes using the antisense oligonucleotides that flourished in the 1980s. Early aspirations for therapeutic applications were almost extinguished by the unexpected complexity of oligonucleotide pharmacology.
openaire   +2 more sources

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Journal of Clinical Medicine, 2020
Karishma Mohan Dhuri   +2 more
exaly  

MODIFIED OLIGONUCLEOTIDES

2023
WAKEFIELD DARREN H   +4 more
openaire   +2 more sources

Amplification oligonucleotides

2023
SHULTZABERGER RYAN   +2 more
openaire   +4 more sources

Oligonucleotide synthesizer

2022
SLAVAZZA DARIO   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy